{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-096923","form_type":"8-K/A","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.696714+00:00","generated_at":"2026-05-18T05:50:47.280452+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"FibroBiologics amends 8-K to disclose up to 41.4M shares issuable under SEPA with YA II PN","bullets":["Maximum shares convertible from $15M promissory notes: 36,945,812 shares at $0.406/share.","Additional maximum shares from Commitment Amount: 4,424,778 shares at $2.26/share.","Agreement with YA II PN, Ltd. was previously disclosed on Dec 20, 2024; amendment adds share counts.","Conversion price subject to anti-dilution adjustments; shares unregistered under Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-096923","json":"https://secwatch.observer/filing/0000950170-25-096923.json","markdown":"https://secwatch.observer/filing/0000950170-25-096923.md","text":"https://secwatch.observer/filing/0000950170-25-096923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000095017025096923/0000950170-25-096923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000095017025096923/fblg-20241220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:50:47.280452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}